Together, our results support a role for ERK5 kinase activity in conferring resistance to TRAIL-induced apoptosis in cancer cells, whereas ERK5 inhibition improves TRAIL anticancer activity by favoring caspase-8 activation. This evidence concerns the gene CASP8 and cancer.